TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26277100

Group type: EXPERIMENTAL
Intervention: Structured interventional harmonisation process
Number of subjects: 11

Group type: COMPARATOR
Intervention: Baseline inter-observer agreement assessment
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Improved reading criteria
Number of subjects: 11
Study: 23142494

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 16825032

Group type: EXPERIMENTAL
Intervention: American Heart Association Step II diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 0
Study: 12811707

Group type: EXPERIMENTAL
Intervention: Eutectic mixture of local anesthetics
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: VAS-based pain comparisons for jellyfish stings
Number of subjects: 40

Group type: COMPARATOR
Intervention: Serial 20- to 30-minute pain comparisons
Number of subjects: 40
Study: 10330942

Group type: EXPERIMENTAL
Intervention: Drainage (n = 248) with 2 multiperforated 14F suction drains
Number of subjects: 494

Group type: COMPARATOR
Intervention: No drainage (n = 246)
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Drainage (n = 248)
Number of subjects: 494
Study: 7560400

Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection with removal of all plaque and calculus in two visits within 24 hours, tongue brushed with 1% chlorhexidine gel, mouth rinsed with 0.2% chlorhexidine solution, subgingival chlorhexidine (1%) irrigation performed in all pockets
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group received scalings and root planings per quadrant at two-week intervals
Number of subjects: 10
Study: 1767639

Group type: EXPERIMENTAL
Intervention: Functional splint
Number of subjects: 63

Group type: COMPARATOR
Intervention: Plaster cast immobilization
Number of subjects: 63
Study: 7102585

Group type: COMPARATOR
Intervention: Control diet (80 mEq K+/day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low K+ diet (25 mEq K+/day)
Number of subjects: 8
Study: 31271654

Group type: EXPERIMENTAL
Intervention: Individualized feedback report and stage-matched brochure
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 79
Study: 28816734

Group type: EXPERIMENTAL
Intervention: Active rest program (short-time exercise) for 10 minutes per day, 3-4 times per week for 8 weeks
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 130
Study: 26472130

Group type: EXPERIMENTAL
Intervention: Pay for performance (P4P) strategy with quarterly incentive payments based on seven performance indicators.
Number of subjects: 11953

Group type: COMPARATOR
Intervention: Control group (comparison arm)
Number of subjects: 11953
Study: 24138688

Group type: EXPERIMENTAL
Intervention: Combination beclometasone/formoterol hydrofluoroalkane (HFA)‐MDI used as both maintenance and reliever therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed dose of maintenance beclometasone/formoterol HFA‐MDI with salbutamol MDI for relief
Number of subjects: 0
Study: 21784838

Group type: EXPERIMENTAL
Intervention: Allopurinol 300 mg/d
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control hyperuricemic group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normouricemic group
Number of subjects: 30
Study: 19792858

Group type: EXPERIMENTAL
Intervention: Polydioxanone (PDS) tent without a guided tissue regeneration (GTR) membrane
Number of subjects: 16
Study: 16766419

Group type: EXPERIMENTAL
Intervention: Nicotine gum (4 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 14
Study: 15234403

Group type: EXPERIMENTAL
Intervention: Reperfusion therapy for acute STEMI
Number of subjects: 5470
Study: 11236835

Group type: EXPERIMENTAL
Intervention: Concurrent treatment for both alcohol and social anxiety problems (n = 49)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Individual cognitive behavioral therapy for alcoholism only (n = 44)
Number of subjects: 93
Study: 9007742

Group type: EXPERIMENTAL
Intervention: Blink reflex (BR) response to supraorbital nerve electrical stimuli
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Late responses elicited on the side of the lesion by stimulation of the non-affected supraorbital nerve
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Overall BR pattern
Number of subjects: 20
Study: 8317644

Group type: EXPERIMENTAL
Intervention: Pethidine 100 mg added to 40 ml prilocaine 0.25%
Number of subjects: 0
Study: 3816105

Group type: EXPERIMENTAL
Intervention: Analog computer
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Linear regression
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Empiric dosing
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 54
Study: 29405762

Group type: EXPERIMENTAL
Intervention: Hot herbal compress
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hot compress
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical diclofenac
Number of subjects: 0
Study: 26610367

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 24597550

Group type: EXPERIMENTAL
Intervention: NMES
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 12
Study: 23702987

Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM)
Number of subjects: 288
Study: 19481278

Group type: EXPERIMENTAL
Intervention: Bisoprolol-first
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Enalapril-first
Number of subjects: 40
Study: 18166191

Group type: EXPERIMENTAL
Intervention: High-dose B-vitamin therapy
Number of subjects: 2124
Study: 16864642

Group type: EXPERIMENTAL
Intervention: Prebronchodilator FEV1% > or = 100%
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Prebronchodilator FEV1% 60% to 79%
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Prebronchodilator FEV1% < 60%
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Mean symptom score (0-3)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Asthma-related events (oral steroid use, emergency department visits, hospitalizations)
Number of subjects: 417
Study: 14650098

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG administered orally in yogurt base (10^9 CFU) for 1 month, 1 or 2 doses per day
Number of subjects: 42
Study: 10894268

Group type: EXPERIMENTAL
Intervention: GART group (genotypic antiretroviral resistance testing)
Number of subjects: 153

Group type: COMPARATOR
Intervention: No-GART group (no genotypic antiretroviral resistance testing)
Number of subjects: 153
Study: 8792320

Group type: EXPERIMENTAL
Intervention: Manual muscle testing while viewing a threat stimulus (cue word on a printed card)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (nonphobic subjects)
Number of subjects: 27
Study: 1638713

Group type: EXPERIMENTAL
Intervention: 1 mg captopril
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 25 mg captopril
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6395280

Group type: EXPERIMENTAL
Intervention: Cefonicid 1 g intravenously or intramuscularly 1 hr before surgery
Number of subjects: 57

Group type: COMPARATOR
Intervention: Cefoxitin 2 g intravenously or intramuscularly 1 hr before surgery and 2 g every 6 hr for 24 hr
Number of subjects: 57
Study: 30536570

Group type: EXPERIMENTAL
Intervention: 3D printed simulator
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional didactic learning
Number of subjects: 35
Study: 30200582

Group type: EXPERIMENTAL
Intervention: Whey Protein (WP, 77 g/day protein, 580 kcal/day)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Whey Protein (WP)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Carbohydrate (CHO, 127 g/day carbohydrate, 580 kcal/day)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 69
Study: 26792906

Group type: EXPERIMENTAL
Intervention: 8-week community program implemented by trained volunteers
Number of subjects: 185
Study: 25734298

Group type: EXPERIMENTAL
Intervention: Chronic suppurative otitis media (CSOM) patients
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) of the temporal bones in patients with CSOM and mucositis
Number of subjects: 390
Study: 22130869

Group type: EXPERIMENTAL
Intervention: Fexofenadine (60 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Olopatadine (5 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20659611

Group type: EXPERIMENTAL
Intervention: Continuous infusion of phenylephrine at 0.15 microg.kg(‐1).min(‐1) after spinal block
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Single dose of prophylactic phenylephrine 50 microg after spinal block
Number of subjects: 120

Group type: COMPARATOR
Intervention: Single dose of phenylephrine 50 microg in case of hypotension
Number of subjects: 120
Study: 17882915

Group type: EXPERIMENTAL
Intervention: 60 mg pseudoephedrine (PSE) four times daily
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 14996592

Group type: EXPERIMENTAL
Intervention: 12 weeks of endurance exercise training
Number of subjects: 0
Study: 12360468

Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b plus ribavirin
Number of subjects: 1521

Group type: EXPERIMENTAL
Intervention: Peginterferon alpha‐2b plus ribavirin
Number of subjects: 1521
Study: 10094742

Group type: EXPERIMENTAL
Intervention: Conventional hernia repair (Shouldice)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endoscopic hernia repair (TEPP)
Number of subjects: 30
Study: 7549843

Group type: EXPERIMENTAL
Intervention: Cryopreserved marrow cells using a mixture of 5% DMSO, 6% HES, and 4% Albumin in Lactated Ringer solution.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cryopreserved marrow cells using 10% DMSO (control group).
Number of subjects: 12
Study: 2379568

Group type: EXPERIMENTAL
Intervention: Reproductive health consultation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 80525

Group type: EXPERIMENTAL
Intervention: Tienilic acid (mean dose 210 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cyclopenthiazide (mean dose 0.41 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tienilic acid
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cyclopenthiazide
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 36
Study: 29446160

Group type: EXPERIMENTAL
Intervention: SPF30 daily skin cream
Number of subjects: 17

Group type: COMPARATOR
Intervention: Non-treated lentigines
Number of subjects: 17
Study: 27689591

Group type: EXPERIMENTAL
Intervention: Background music with lyrics
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Background music that implies feeling 'loved'
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Music that makes listeners feel sad
Number of subjects: 65
Study: 24736770

Group type: EXPERIMENTAL
Intervention: Low Load (LL: 5% BM)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Medium Load (ML: 12.5% BM)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High Load (HL: 20% BM)
Number of subjects: 19
Study: 24159176

Group type: COMPARATOR
Intervention: Germline and somatic variations of TNFAIP3
Number of subjects: 574

Group type: EXPERIMENTAL
Intervention: Functional abnormalities of A20
Number of subjects: 574
Study: 20812851

Group type: EXPERIMENTAL
Intervention: IFN‐γ responses to Ag85
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: IFN‐γ responses to ESAT‐6
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: IFN‐γ responses to WCL
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: Baseline LPA responses
Number of subjects: 979
Study: 18388901

Group type: EXPERIMENTAL
Intervention: Added Support (AS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard Support (SS)
Number of subjects: 42
Study: 17600973

Group type: EXPERIMENTAL
Intervention: Carraguard gel
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Monthly visit schedule preference
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Willingness to use product
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Product use over time
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Trial design flexibility
Number of subjects: 200

Group type: COMPARATOR
Intervention: Condoms-only arm
Number of subjects: 200
Study: 11158407

Group type: EXPERIMENTAL
Intervention: Continuous venovenous haemofiltration (CVVH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intermittent haemodialysis (IHD)
Number of subjects: 30
Study: 9921701

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 623
Study: 8117177

Group type: EXPERIMENTAL
Intervention: Micronized fenofibrate (200 mg daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Switching from fenofibrate to simvastatin
Number of subjects: 60
Study: 2455414

Group type: EXPERIMENTAL
Intervention: Etretinate + PUVA treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etretinate monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etretinate treatment (control side)
Number of subjects: 0
Study: 2071980

Group type: EXPERIMENTAL
Intervention: Multidrug therapy (MDT) for paucibacillary leprosy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Dapsone (DDS) monotherapy
Number of subjects: 54
Study: 40572

Group type: EXPERIMENTAL
Intervention: 10 mg temazepam with alcohol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 mg temazepam with alcohol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 30 mg temazepam with alcohol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30346855

Group type: EXPERIMENTAL
Intervention: 5-Hydroxymethylfurfural and Alpha-Ketoglutaric Acid (5-HMF/α-KG)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 30699425

Group type: EXPERIMENTAL
Intervention: Early total enteral feeding (ETEF)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional enteral feeding (CEF)
Number of subjects: 180
Study: 28219107

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 12 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (CG) - no physical exercise
Number of subjects: 35
Study: 25901453

Group type: EXPERIMENTAL
Intervention: Family Healthware™ intervention
Number of subjects: 3786
Study: 23704198

Group type: EXPERIMENTAL
Intervention: Copenhagen Physical Activity after Cancer Treatment (PACT)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Health Evaluation Program (HE)
Number of subjects: 214
Study: 21339010

Group type: EXPERIMENTAL
Intervention: Intra-operative radiation therapy (IORT) combined with surgical resection (n=73)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Surgical resection alone (Control group: n=69)
Number of subjects: 142
Study: 19013603

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg for 1 week run-in and 100 mg for 3 weeks)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 17804354

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) including routine depression screening and staff training in depression care management
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Intervention group (INT) including antidepressants and/or psychotherapy treatment plus EUC
Number of subjects: 311
Study: 15197190

Group type: EXPERIMENTAL
Intervention: Vinblastine, methotrexate with calcium leucovorin rescue, and fluorouracil (VbMF)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Vincristine, doxorubicin, cyclophosphamide, and prednisone (VACP)
Number of subjects: 193

Group type: COMPARATOR
Intervention: VACP (additional cycles)
Number of subjects: 193
Study: 12022217

Group type: EXPERIMENTAL
Intervention: Intrathecal midazolam (2 mg) with 1.5 ml of 5% lignocaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1.5 ml of 5% lignocaine only
Number of subjects: 40
Study: 9520891

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 19

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 19
Study: 8013688

Group type: EXPERIMENTAL
Intervention: Autologous mononuclear cells (MNC)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Tissue culture medium alone (Control)
Number of subjects: 33
Study: 2492235

Group type: EXPERIMENTAL
Intervention: Follicle-stimulating hormone (FSH) administered at different times during the menstrual cycle
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate, 100 mg/day for days 2 to 6; FSH, 150 units/day for days 1 to 4; human menopausal gonadotropin, 150 units/day from day 5 until hCG administration
Number of subjects: 67
Study: 4618908

Group type: EXPERIMENTAL
Intervention: Controlled trials of treatment for liver disease in children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlled trials
Number of subjects: 0
Study: 31654838

Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg
Number of subjects: 197

Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 197
Study: 27717996

Group type: EXPERIMENTAL
Intervention: 4 mg doxazosin
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 8 mg doxazosin
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (hydration and analgesics only)
Number of subjects: 66
Study: 26234955

Group type: EXPERIMENTAL
Intervention: Peer Network Counseling intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 119
Study: 23941542

Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone implant
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral steroids
Number of subjects: 20
Study: 21306624

Group type: EXPERIMENTAL
Intervention: Manualized 12-week CBT intervention for anger delivered by trained day-service staff
Number of subjects: 0

Group type: COMPARATOR
Intervention: Support as usual waiting-list control group
Number of subjects: 0
Study: 19209072

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endurance cycling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 16897286

Group type: EXPERIMENTAL
Intervention: Tannenbaum stent (n = 24)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Uncovered self-expandable metal stent (n = 23)
Number of subjects: 47
Study: 16113424

Group type: EXPERIMENTAL
Intervention: Combination therapy with budesonide and formoterol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination therapy with inhaled corticosteroids and long-acting beta-agonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled bronchodilators (tiotropium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pulmonary rehabilitation
Number of subjects: 0
Study: 11780699

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel chemotherapy and new biologic agents
Number of subjects: 0
Study: 9623560

Group type: EXPERIMENTAL
Intervention: Pulse calcitriol (3.0 microg twice a week)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Daily calcitriol (0.75 microg a day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (pulse and daily calcitriol)
Number of subjects: 18
Study: 7843579

Group type: EXPERIMENTAL
Intervention: Triazolam (0.125 mg, with option to increase to 0.25 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 3281016

Group type: EXPERIMENTAL
Intervention: Educational intervention focusing on diet, physical activity, and cigarette smoking.
Number of subjects: 1769
Study: 29779884

Group type: EXPERIMENTAL
Intervention: SMASH-U classification system
Number of subjects: 156

Group type: COMPARATOR
Intervention: H-ATOMIC classification system
Number of subjects: 156
Study: 27177525

Group type: EXPERIMENTAL
Intervention: Last exposure to magnesium <12 hours prior to delivery
Number of subjects: 906

Group type: COMPARATOR
Intervention: Last exposure to magnesium ≥12 hours prior to delivery
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (moderate/severe cerebral palsy and moderate/severe cerebral palsy or death)
Number of subjects: 906
Study: 24114891

Group type: EXPERIMENTAL
Intervention: Recruitment manoeuvre (RM) after suctioning
Number of subjects: 54

Group type: COMPARATOR
Intervention: No recruitment manoeuvre (NRM)
Number of subjects: 54
Study: 22085043

Group type: EXPERIMENTAL
Intervention: Microbicide research involvement
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Trial participation disclosure
Number of subjects: 28
Study: 21186536

Group type: EXPERIMENTAL
Intervention: PEG‐interferon alpha‐2a (PEG‐IFNalpha‐2a)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Adefovir dipivoxil (ADV)
Number of subjects: 81
Study: 18703440

Group type: EXPERIMENTAL
Intervention: Combined pharmacologic and behavioral smoking cessation intervention (10-week group intervention + nicotine replacement therapy)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 250
Study: 15989013

Group type: EXPERIMENTAL
Intervention: noliprel (2 mg/0.625 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: caposide (50 mg/25 mg)
Number of subjects: 40
Study: 12028720

Group type: EXPERIMENTAL
Intervention: Virtual Environment (VE) condition
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: VE 2(1/2)-D task
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: VE 2(1/2)-D with added background
Number of subjects: 30

Group type: COMPARATOR
Intervention: Real World (RW) task
Number of subjects: 30
Study: 10520389

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 7486272

Group type: EXPERIMENTAL
Intervention: Aprotinin (APR)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TRA)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (CTR)
Number of subjects: 104
Study: 2326520

Group type: EXPERIMENTAL
Intervention: Loss of resistance technique (Group I, n = 35)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Episensor technique (Group II)
Number of subjects: 71